📰 Susane Burwig News
Susane Burwig News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Susane Burwig. Real-time updates on events, politics, business and more.
June 12, 2024
Mairs & Power Inc. lessened its position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 15.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,189 shares of the company’s stock after selling 5,902 shares during the […]
June 10, 2024
Ranger Investment Management L.P. cut its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 26.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 138,744 shares of the company’s stock after selling 50,958 shares during the quarter. Medpace accounts for 2.6% […]
June 8, 2024
Prudential PLC boosted its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 12.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 24,288 shares of the company’s stock after purchasing an additional 2,762 shares during the quarter. Prudential PLC owned about 0.08% of […]
June 2, 2024
Eagle Asset Management Inc. lifted its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 155.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 226,435 shares of the company’s stock after acquiring an additional 137,632 shares during the quarter. […]
May 30, 2024
Analysts at Mizuho started coverage on shares of Medpace (NASDAQ:MEDP – Get Free Report) in a report issued on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $435.00 price target on the stock. Mizuho’s price objective would suggest a potential upside of 12.12% from the company’s current price. Several other analysts […]
May 30, 2024
Equities research analysts at Mizuho initiated coverage on shares of Medpace (NASDAQ:MEDP – Get Free Report) in a note issued to investors on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $435.00 price target on the stock. Mizuho’s price objective would indicate a potential upside of 12.12% from the company’s previous close. […]
May 7, 2024
Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report)’s stock price traded up 1.6% on Monday . The stock traded as high as $403.12 and last traded at $398.85. 61,611 shares traded hands during trading, a decline of 75% from the average session volume of 247,262 shares. The stock had previously closed at $392.57. Analyst Upgrades […]
May 1, 2024
Shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) were up 1.2% during trading on Monday . The company traded as high as $401.99 and last traded at $400.82. Approximately 27,821 shares changed hands during mid-day trading, a decline of 89% from the average daily volume of 248,000 shares. The stock had previously closed […]
May 1, 2024
Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) shares traded down 0.3% during mid-day trading on Wednesday . The stock traded as low as $386.42 and last traded at $387.29. 39,505 shares changed hands during trading, a decline of 84% from the average session volume of 247,935 shares. The stock had previously closed at $388.35. […]
April 27, 2024
Jefferies Financial Group upgraded shares of Medpace (NASDAQ:MEDP – Free Report) from a hold rating to a buy rating in a report issued on Tuesday morning, MarketBeat Ratings reports. The brokerage currently has $450.00 price target on the stock, up from their previous price target of $340.00. A number of other equities analysts have also […]